ONO-4538 Study in Patients With Richter's Transformation

PHASE2RecruitingINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

July 31, 2029

Study Completion Date

July 31, 2030

Conditions
Richter's Transformation
Interventions
DRUG

ONO-4538

every 4 weeks

Trial Locations (8)

Unknown

NOT_YET_RECRUITING

Aichi Cancer Center, Nagoya

NOT_YET_RECRUITING

Tohoku University Hospital, Sendai

NOT_YET_RECRUITING

Niigata University Medical & Dental Hospital, Niigata

RECRUITING

Kindai University Hospital, Ōsaka-sayama

NOT_YET_RECRUITING

Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Bunkyō-Ku

RECRUITING

National Cancer Center Hospital, Chuo Ku

812-8582

RECRUITING

Kyusyu University Hospital, Fukuoka

060-8648

RECRUITING

Hokkaido University Hospital, Sapporo

Sponsors
All Listed Sponsors
lead

Ono Pharmaceutical Co. Ltd

INDUSTRY

NCT06936943 - ONO-4538 Study in Patients With Richter's Transformation | Biotech Hunter | Biotech Hunter